Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review

被引:10
|
作者
Visco, Diego Bulcao [1 ]
Manhaes-de-Castro, Raul [2 ]
Chaves, Wenicios Ferreira [1 ]
Lacerda, Diego Cabral [1 ]
Pereira, Sabrina da Conceicao [3 ]
Ferraz-Pereira, Kelli Nogueira [4 ]
Toscano, Ana Elisa [5 ]
机构
[1] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Postgrad Program Phys Therapy, Recife, PE, Brazil
[4] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, PE, Brazil
[5] Univ Fed Pernambuco, CAV, Dept Nursing, Rua Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil
关键词
Serotonin uptake inhibitors; Serotonin; Skeletal muscle; Systematic review; CONGENITAL MYASTHENIC SYNDROME; CUTANEOUS SILENT PERIOD; FLUOXETINE TREATMENT; MYOTONIC-DYSTROPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; NEONATAL TREATMENT; DIABETES-MELLITUS; RAT; ANTIDEPRESSANTS;
D O I
10.1016/j.phrs.2018.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective Serotonin Reuptake Inhibitors (SSRIs) may have side effects, such as stiffness, tremors and altered tonic activity, as well as an increased risk of developing insulin resistance and diabetes mellitus. However, little is known about the structural, functional and metabolic changes of skeletal muscle after administration of SSRIs. The aim of this systematic review was to explore and discuss the effects of SSRIs on skeletal muscle properties described in human and rodent studies. A systematic search of PUBMED, SCOPUS, and WEB OF SCIENCE was performed. The inclusion criteria were intervention studies in humans and rodents that analysed the effects of SSRIs on skeletal muscle properties. The research found a total of six human studies, including two randomized controlled trials, one non-randomized controlled trial, one uncontrolled before-after study and two case reports, and six preclinical studies in rodents. Overall, the studies in humans and rodents showed altered electrical activity in skeletal muscle function, assessed through electromyography (EMG) and needle EMG in response to chronic treatment or local injection with SSRIs. In addition, rodent studies reported that SSRIs may exert effects on muscle weight, the number of myocytes and the cross-sectional area of skeletal muscle fibre. The results showed effects in energy metabolism associated with chronic SSRI use, reporting altered levels of glycogen synthase activity, acetyl-CoA carboxylase phosphorylation, citrate synthase activity, and protein kinase B Ser phosphorylation. Moreover, changes in insulin signalling and glucose uptake were documented. In this context, we concluded based on human and rodent studies that SSRIs affect electrical muscle activity, structural properties and energy metabolism in skeletal muscle tissue. However, these changes varied according to pre-existing metabolic and functional conditions in the rodents and humans.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 50 条
  • [41] Selective serotonin reuptake inhibitors: measurement of effect on platelet function
    McCloskey, Donna Jo
    Postolache, Teodor T.
    Vittone, Bernard J.
    Nghiem, Khanh L.
    Monsale, Jude L.
    Wesley, Robert A.
    Rick, Margaret E.
    TRANSLATIONAL RESEARCH, 2008, 151 (03) : 168 - 172
  • [42] Selective Serotonin Reuptake Inhibitors Suppress Mast Cell Function
    Haque, Tamara
    Ryan, John J.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [43] Selective Serotonin Reuptake Inhibitors Suppress Mast Cell Function
    Haque, Tamara
    Ryan, John
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [44] Selective serotonin reuptake inhibitors and withdrawal symptoms: A review of the literature
    Therrien, F
    Markowitz, JS
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (04) : 309 - 323
  • [45] Effects of selective serotonin reuptake inhibitors on endocrine system (Review)
    Ruiz-Santiago, Carolina
    Rodriguez-Pinacho, Carla Valeria
    Perez-Sanchez, Gilberto
    Acosta-Cruz, Erika
    BIOMEDICAL REPORTS, 2024, 21 (03)
  • [46] A review of the safety of selective serotonin reuptake inhibitors during pregnancy
    Goldstein, DJ
    Sundell, K
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1999, 14 (05) : 319 - 324
  • [47] The economics of selective serotonin reuptake inhibitors in depression - A critical review
    Frank, L
    Revicki, DA
    Sorensen, SV
    Shih, YCT
    CNS DRUGS, 2001, 15 (01) : 59 - 83
  • [48] Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
    Edinoff, Amber N.
    Akuly, Haseeb A.
    Hanna, Tony A.
    Ochoa, Carolina O.
    Patti, Shelby J.
    Ghaffar, Yahya A.
    Kaye, Alan D.
    Viswanath, Omar
    Urits, Ivan
    Boyer, Andrea G.
    Cornett, Elyse M.
    Kaye, Adam M.
    NEUROLOGY INTERNATIONAL, 2021, 13 (03) : 387 - 401
  • [49] Selective serotonin reuptake inhibitors in pediatric psychopharmacology: A review of the evidence
    Hammerness, PG
    Vivas, FM
    Geller, DA
    JOURNAL OF PEDIATRICS, 2006, 148 (02): : 158 - 165
  • [50] The Economics of Selective Serotonin Reuptake Inhibitors In DepressionA Critical Review
    Lori Frank
    Dennis A. Revicki
    Sonja V. Sorensen
    Ya-Chen Tina Shih
    CNS Drugs, 2001, 15 : 59 - 83